Mirae Asset Global ETFs Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$559K	Buy	44,871 +2,797	+7%	+$37.5K	﹤0.01%	1943
2026 Q1	$613K	Buy	42,074 +11,806	+39%	+$263K	﹤0.01%	1782
2025 Q4	$757K	Buy	30,268 +2,934	+11%	+$52.2K	﹤0.01%	1675
2025 Q3	$268K	Buy	+27,334	New	+$164K	﹤0.01%	2165
2025 Q2	–	Sell	-23,932	Closed	-$90K	–	3170
2025 Q1	$90K	Sell	23,932 -2,284	-9%	-$11.5K	﹤0.01%	2681
2024 Q4	$152K	Buy	26,216 +724	+3%	+$7.23K	﹤0.01%	2523
2024 Q3	$305K	Buy	25,492 +8,636	+51%	+$110K	﹤0.01%	2158
2024 Q2	$184K	Buy	+16,856	New	+$183K	﹤0.01%	2303

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's OLMA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Olema Pharmaceuticals (OLMA) stake by 6.6% in Q2 2026, buying an estimated $37.5K and bringing the position to 44,871 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

Mirae Asset Global ETFs Holdings first reported a position in OLMA in Q2 2024 and has held it in 8 quarters since. The position peaked at $757K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 44,871 shares of Olema Pharmaceuticals worth $559K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 2,797 Olema Pharmaceuticals shares in Q2 2026, an estimated $37.5K.
Olema Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1943 holding.
Mirae Asset Global ETFs Holdings first reported a position in Olema Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Olema Pharmaceuticals position peaked at $757K in Q4 2025.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.